XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Follow On Public Offering
Common Stock
Common Stock
Follow On Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Follow On Public Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     22,692        
Beginning balance at Dec. 31, 2023 $ 708,052   $ 2   $ 796,450   $ (88,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 67,162       67,162    
Net loss (74,788)           (74,788)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs (in shares)     233        
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs 28,375       28,375    
Issuance of common stock in connection with At-The-Marker offering net of underwriting discounts and commissions and other offerings costs (in shares)     233        
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 28,375       28,375    
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     437        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (32,566)       (32,566)    
Ending balance (in shares) at Sep. 30, 2024     23,362        
Ending balance at Sep. 30, 2024 696,235   $ 2   859,421   (163,188)
Beginning balance (in shares) at Jun. 30, 2024     23,132        
Beginning balance at Jun. 30, 2024 692,512   $ 2   836,383   (143,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 21,915       21,915    
Net loss (19,315)           (19,315)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs (in shares)     100        
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs 13,321       13,321    
Issuance of common stock in connection with At-The-Marker offering net of underwriting discounts and commissions and other offerings costs (in shares)     100        
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 13,321       13,321    
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     130        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (12,198)       (12,198)    
Ending balance (in shares) at Sep. 30, 2024     23,362        
Ending balance at Sep. 30, 2024 $ 696,235   $ 2   859,421   (163,188)
Beginning balance (in shares) at Dec. 31, 2024 23,598   23,598        
Beginning balance at Dec. 31, 2024 $ 699,719   $ 2   881,718   (182,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 79,990       79,990    
Net loss (52,070)           (52,070)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs (in shares)     150 2,012      
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs 29,695 $ 387,338 $ 1   29,695 $ 387,337  
Issuance of common stock in connection with At-The-Marker offering net of underwriting discounts and commissions and other offerings costs (in shares)     150 2,012      
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 29,695 387,338 $ 1   29,695 387,337  
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     341        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings $ (41,269)       (41,269)    
Ending balance (in shares) at Sep. 30, 2025 26,101   26,101        
Ending balance at Sep. 30, 2025 $ 1,103,403   $ 3   1,337,471   (234,071)
Beginning balance (in shares) at Jun. 30, 2025     26,004        
Beginning balance at Jun. 30, 2025 1,100,681   $ 3   1,326,735   (226,057)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 24,711       24,711    
Net loss (8,014)           (8,014)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs   9       9  
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs   $ 9       $ 9  
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     97        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings $ (13,984)       (13,984)    
Ending balance (in shares) at Sep. 30, 2025 26,101   26,101        
Ending balance at Sep. 30, 2025 $ 1,103,403   $ 3   $ 1,337,471   $ (234,071)